Cryptobiotix
cRG-I, a precision prebiotic with consistent effect
Carrot RG-I, a precision prebiotic with consistent effect
0
Cryptobiotix

Van den Abbeele et al, 2023, Nutrients

Gut microbiome research suffers from low predictivity, which is caused by interpersonal differences in microbiota composition. The specificity of prebiotics may be used to steer the composition of the gut microbiome and consequently guide towards more predictive research outcomes. This study compared the selectivity of carrot RG-I (cRG-I) to two other substrates, inulin (IN) and xanthan (XA), and found that cRG-I supplementation led to a homogenisation of gut microbial composition and metabolite production across individuals. This contrasted with IN and XA, which increased interpersonal differences. The study involved 24 human adults and utilized the ex vivo SIFR® technology, which combines high throughput with precision and is validated to generate predictive insights for clinical findings. Key findings from the study include that cRG-I selectively stimulated taxa consistently present among human adults, including those related to keystone species and butyrate-producing taxa. Additionally, cRG-I altered fermentation activity, producing higher acetate and propionate and generating less gas than IN. The results suggest that the specificity of cRG-I could lead to more predictable outcomes compared to less specific or overly specific substrates.

SIFR® predictive for clinical changes in gut microbiota composition
0
Cryptobiotix

Van den Abbeele et al, 2023, Frontiers in Microbiology

The translation of preclinical findings into valid clinical outcomes remains an issue to this day. This “Valley of Death” is very present in gut microbiome research due to the intractability of gut microbiome interactions in vivo.The ex vivo SIFR® technology successfully predicted shifts in the gut microbiota composition observed in vivo across different interventions (inulin, resistant dextrin, 2’FL). This predictivity for clinical outcomes enables the quick generation of mechanistic hypotheses, while the high throughput of the technology embraces the inter-individual variation at the preclinical stage to de-risk clinical trials on the responder/non-responder question.

Want to know more?
Synbiotic discovery: tributyrin & Lactobacillaceae
0
Cryptobiotix

Van den Abbeele et al, 2023, International Journal of Molecular Sciences

After ascertaining the prebiotic potential of tributyrin in a first study, we wanted to discover synbiotic combination further stimulating butyrate production. Relying on the high throughput of the ex vivo SIFR® technology, an exhaustive investigation was set up for the prebiotic (tributyrin) and the probiotics (Lacticaseibacillus rhamnosus GG, Limosilactobacillus reuteri), alone or in combination. To account for inter-individual variations, the gut microbiota of 6 donors was tested in parallel. The experiment confirmed that, while each molecule of tributyrin is easily converted to 3 butyrate on its own, the addition of Lacticaseibacillus rhamnosus GG or Limosilactobacillus reuteri opened an additional pathway of conversion through butyrate by first converting tributyrin-derived glycerol to lactate, which could in turn could be metabolised to butyrate by the endemic microorganism Coprococcus catus.

Prebiotic investigation of immunoglobulin
0
Cryptobiotix

Van den Abbeele et al, 2023, Microorganisms.

Various bovine plasma fractions were investigated for their prebiotic potential and mechanism of action. To ensure a biorelevant research, the colonic SIFR simulation was preceded by a digestion and absorption step. The immunoglobulin fraction exhibited the most pronounced prebiotic potential. It was used specifically by Bacteroides vulgatus, Lachnoclostridium edouardi and Coprococcus comes, leading to the production of health-promoting SCFA (acetate, propionate & butyrate).